Quantum Dot launches first product

Nov. 18, 2002 — Quantum Dot Corp. said it has launched its first product based on nanobiotechnology.

The Qdot 605 Streptavidin Conjugate, the first in a planned line of Qdot products, consists of a multilayered semiconductor nanocrystal attached to streptavidin, a specific biomolecule. Applications include cell and tissue analysis for drug discovery, according to a company news release.

Quantum dots brightly light up specific biological events. The nanoscale light-emitting diodes allow rapid, parallel and ultrasensitive detection of biomolecular interactions, and are thought to accelerate and reduce the costs of developing and evaluating drug candidates.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.